Showing results (1591-1600 of 3,792) with videos related to
Sort By:
Pageof 380
Oncoimmunology|April 9, 2016
Mammaglobin-A is a target for breast cancer vaccinationSamuel W Kim, Peter Goedegebuure, William E GillandersOncoimmunology|April 9, 2016
Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg)F Figueiró, L Muller, S Funk, et al.Oncoimmunology|April 9, 2016
Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cellsErika Vacchelli, Michaela Semeraro, Julien Adam, et al.Oncoimmunology|April 9, 2016
TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancerSylvian Bron, Luc Henry, Eveline Faes-Van't Hull, et al.Oncoimmunology|April 9, 2016
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccinationDiana Llopiz, Fernando Aranda, Nancy Díaz-Valdés, et al.Oncoimmunology|April 9, 2016
Systemic inflammation: Cancer's long-distance reach to maximize metastasisSeth B Coffelt, Karin E de VisserOncoimmunology|April 9, 2016
The next step toward GMP-grade production of engineered immune cellsGuido J J Kierkels, Trudy Straetemans, Moniek A de Witte, et al.Oncoimmunology|April 9, 2016
Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cellsLiang Zhang, Huanyu Wang, Tianshu Yang, et al.Oncoimmunology|April 9, 2016
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancerSimona Bramante, Anniina Koski, Ilkka Liikanen, et al.Oncoimmunology|April 9, 2016
The colorectal cancer immune paradox revisitedMihaela Angelova, Pornpimol Charoentong, Hubert Hackl, et al.Pageof 380